Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Xiaojuan Mi"'
Autor:
Janet H. Ford, Wenyu Ye, David W. Ayer, Xiaojuan Mi, Swati Bhandari, Dawn C. Buse, Richard B. Lipton
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-15 (2023)
Abstract Background No available studies demonstrate validity and meaningful change thresholds of Work Productivity and Activity Impairment (WPAI) questionnaire in patients with migraine. In this post-hoc analysis, we assessed reliability, validity,
Externí odkaz:
https://doaj.org/article/9cc0c676c6dc4733ae10cfbe5f41aaf3
Autor:
Adam D. DeVore, Xiaojuan Mi, Laine Thomas, Puza P. Sharma, Nancy M. Albert, Javed Butler, Adrian F. Hernandez, J. Herbert Patterson, John A. Spertus, Fredonia B. Williams, Carol I. Duffy, Kevin McCague, Gregg C. Fonarow
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 12 (2018)
Background The US Food and Drug Administration approved sacubitril/valsartan for patients with chronic heart failure (HF) with reduced ejection fraction in 2015 on the basis of the results of the PARADIGM‐HF (Prospective Comparison of ARNI [Angiote
Externí odkaz:
https://doaj.org/article/1ae5053f8c89415cacbe7298ff71a0e6
Autor:
Michael G. Nanna, Ann Marie Navar, Tracy Y. Wang, Xiaojuan Mi, Salim S. Virani, Michael J. Louie, L. Veronica Lee, Anne C. Goldberg, Veronique L. Roger, Jennifer Robinson, Eric D. Peterson
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 10 (2018)
BackgroundCurrent statin use and symptoms among older adults in routine community practice have not been well characterized since the release of the 2013 American College of Cardiology/American Heart Association guideline. Methods and ResultsWe compa
Externí odkaz:
https://doaj.org/article/cbebc59e4d734dd8ad6bc3524868d19a
Galcanezumab (GMB) improved quality-of-life and reduced disability of patients with episodic (EM) and chronic migraine (CM) in Phase 3 trials. To estimate indirect cost savings associated with GMB treatment in patients with migraine in the United Sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a52722049ae4fbd6a6177b7a1bb650f
Publikováno v:
Alzheimer's & Dementia. 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af5c04c7671bd668bf602468fd6d7c97
https://doi.org/10.1002/alz.066611
https://doi.org/10.1002/alz.066611
Autor:
Kay-Won Chang, Xiaojuan Mi, Roland A. Matsouaka, Lee H. Schwamm, Jonathan C. Hsu, Gregg C. Fonarow, Barbara L. Lytle, Ying Xian, Shreyansh Shah, Deepak L. Bhatt, Eric E. Smith, Xin Zhao
Publikováno v:
International Journal of Cardiology. 321:88-94
Background To determine association of discharge antiplatelet therapy prescription with 1-year outcomes among patients with AF admitted with acute ischemic stroke and discharged without oral anticoagulation. Methods In a retrospective cohort study fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2e005236220e23072d44b816bb55f6
https://doi.org/10.1016/j.ijcard.2020.08.011
https://doi.org/10.1016/j.ijcard.2020.08.011
Autor:
Joshua Tobin, Janet H. Ford, Antje Tockhorn-Heidenreich, Russell M. Nichols, Wenyu Ye, Rohit Bhandari, Xiaojuan Mi, Karan Sharma, Richard B. Lipton
Publikováno v:
Journal of medical economics. 25(1)
This post-hoc analysis estimated annual indirect cost savings with galcanezumab (GMB) treatment in patients with episodic migraine (EM) or chronic migraine (CM). Data from 4 randomized, Phase 3, double-blind (DB), placebo (PBO)-controlled studies of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0896bfe7883f17f5ec0e282d7c474ad9
https://pubmed.ncbi.nlm.nih.gov/35510376
https://pubmed.ncbi.nlm.nih.gov/35510376
Publikováno v:
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 37(7)
Objective To investigate the effect of inner mitochondrial membrane peptidase 2-like (IMMP2L) gene mutation on cerebral ischemic injury and its mechanism. Methods The cerebral ischemia/reperfusion (I/R) model was established in wild-type (WT) mice an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c504a30383e67b834aa18fe05f7c4570
https://pubmed.ncbi.nlm.nih.gov/34140073
https://pubmed.ncbi.nlm.nih.gov/34140073
Autor:
Nancy M. Albert, Adam D. DeVore, Krishna Patel, Puza P. Sharma, Yevgeniy Khariton, Javed Butler, J. Herbert Patterson, Laine Thomas, Kevin McCague, Xiaojuan Mi, Fredonia B. Williams, Adrian F. Hernandez, Gregg C. Fonarow, Carol I. Duffy, Poghni A. Peri-Okonny, John A. Spertus
Publikováno v:
JACC: Heart Failure. 7:350-358
Objectives This study sought to determine the rate of use of target doses of foundational guideline-directed medical therapy (GDMT) in a contemporary cohort of patients with heart failure with reduced ejection fraction (HFrEF) across systolic blood p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bff8303936221cc23f6dd824c380d14
https://doi.org/10.1016/j.jchf.2018.11.011
https://doi.org/10.1016/j.jchf.2018.11.011
Autor:
Xiaojuan Mi, Salim S. Virani, Eric D. Peterson, Shuang Li, Ann Marie Navar, Tracy Y. Wang, Zhuokai Li, Jennifer G. Robinson
Publikováno v:
Circ Cardiovasc Qual Outcomes
Background: Cardiovascular prevention guidelines use estimated 10-year atherosclerotic cardiovascular disease (CVD) risk based on the pooled cohort equations to guide treatment decisions and engage patients in shared decision-making. We sought to det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ad438763752325c3669c8f877a91ff5
https://doi.org/10.1161/circoutcomes.120.006548
https://doi.org/10.1161/circoutcomes.120.006548